Shaanxi Kanghui Pharmaceutical Hits Day Low at CNY 24.20 Amid Price Pressure

Shaanxi Kanghui Pharmaceutical Co., Ltd. experienced significant volatility on March 23, 2026, with the stock declining by 7.32% and reaching an intraday low of CNY 24.20. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.63% on the same day. Over the past week, Shaanxi Kanghui has seen a more pronounced decline of 14.25%, while its monthly performance remains slightly positive at 1.83%. However, the company has faced challenges over the longer term, with a notable annual return of 18.02% and a year-to-date performance of 19.35%, both outperforming the Shanghai Composite. Despite these figures, the company has reported operating losses and a weak long-term fundamental strength, with a debt-to-equity ratio of 0.81. The stock's performance has been marked by a decline in profits, which fell by 93.5% over the past year, raising concerns about its financial stability. Shaanxi Kanghui's market capitalization stands at CNY 1,287 million, categorizing it as a small-cap entity within the pharmaceuticals and biotechnology industry.